Clifton Mo, MD, presents data from the INSURE study, a pooled analysis evaluating patients with relapsed/refractory multiple myeloma treated with Ixazomib-Lenalidomide-Dexamethasone (IRd). Shonali ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results